Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$154.5B | 8.3 | 67.0% | 17.0% | 23.1% | 11.0% | 14.6% | 117.3% | |
$242.4B | 8.2 | 55.6% | 16.6% | 25.9% | 31.9% | 15.1% | 47.4% | |
$150.5B | 8.4 | 62.8% | 16.8% | 19.8% | 13.2% | 15.4% | 116.5% | |
$120.9B | 8.0 | 52.7% | 18.2% | 22.2% | 12.8% | 16.5% | 127.6% | |
$43.4B | 8.0 | 77.8% | 27.2% | 29.0% | 70.8% | 8.6% | 12.1% | |
$34.9B | 7.8 | 60.4% | 14.9% | 22.7% | 14.3% | 11.3% | 78.8% | |
$24.7B | 6.2 | 43.1% | 2.9% | 5.5% | (3.9%) | 1.5% | (31.1%) | |
$21.9B | 8.2 | 44.7% | 17.7% | 22.7% | 8.7% | 13.9% | 120.6% | |
$21.6B | 8.3 | 64.3% | 16.6% | 32.0% | 11.7% | 20.0% | 125.2% | |
$19.4B | 9.0 | 76.4% | 16.3% | 21.6% | 22.0% | 15.9% | 72.4% | |
$13.6B | 8.2 | 70.3% | 16.0% | 18.7% | 10.5% | 15.6% | 147.8% |
The Boston Scientific Corporation (BSX) gross profit margin is 67.0%, compared to the industry median of 60.9% and the 5-year historical average of 67.8%.
The Boston Scientific Corporation (BSX) operating income margin is 13.6%, compared to the industry median of (5.3%)) and the 5-year historical average of 8.0%.
The Boston Scientific Corporation (BSX) Free Cash Flow margin is 14.6%, compared to the industry median of 0.9% and the 5-year historical average of 10.3%.
The Boston Scientific Corporation (BSX) earnings quality is 117.3%, compared to the industry median of 77.6% and the 5-year historical average of 64.4%.